Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1936 AL 1950

[Patients with Parkinson's disease in hospital]

Eschle D.

Praxis (Bern 1994). 2012 May 9;101(10):651-9. doi: 10.1024/1661-8157/a000939.

Prion-like spread of protein aggregates in neurodegeneration

Polymenidou M, Cleveland DW.

J Exp Med. 2012 May 7;209(5):889-93. doi: 10.1084/jem.20120741.

Boomerang sign: Clinical significance of transient lesion in splenium of corpus callosum

Malhotra HS, Garg RK, Vidhate MR, Sharma PK.

Ann Indian Acad Neurol. 2012 Apr;15(2):151-7. doi: 10.4103/0972-2327.95005.

[Role of septin cytoskeleton in dopaminergic neurotransmission and neurodegeneration]

Kinoshita M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2012 Feb;32(1):25-9.

Case for diagnosis

Silva SB, Miot HA.

An Bras Dermatol. 2012 Mar-Apr;87(2):319-21. doi: 10.1590/s0365-05962012000200025.

[Cerebrospinal fluid and plasma biomarkers for dementia with lewy bodies]

Kasuga K, Ikeuchi T.

Brain Nerve. 2012 May;64(5):505-13.

Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders

Shen LH, Liao MH, Tseng YC.

J Biomed Biotechnol. 2012;2012:259349. doi: 10.1155/2012/259349. Epub 2012 Apr 10.

Dopamine agonists and the suppression of impulsive motor actions in Parkinson disease

Wylie SA, Claassen DO, Huizenga HM, Schewel KD, Ridderinkhof KR, Bashore TR, van den Wildenberg WP.

J Cogn Neurosci. 2012 Aug;24(8):1709-24. doi: 10.1162/jocn_a_00241. Epub 2012 May 9.

Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease

Wang LS, Leung YY, Chang SK, Leight S, Knapik-Czajka M, Baek Y, Shaw LM, Lee VM, Trojanowski JQ, Clark CM.

J Alzheimers Dis. 2012;31(2):439-45. doi: 10.3233/JAD-2012-120082.

The role of central nervous system development in late-onset neurodegenerative disorders

Palubinsky AM, Martin JA, McLaughlin B.

Dev Neurosci. 2012;34(2-3):129-39. doi: 10.1159/000336828. Epub 2012 May 8.

β band stability over time correlates with Parkinsonian rigidity and bradykinesia

Little S, Pogosyan A, Kuhn AA, Brown P.

Exp Neurol. 2012 Aug;236(2):383-8. doi: 10.1016/j.expneurol.2012.04.024. Epub 2012 May 1.

Smoking-induced transient motor deterioration in a levodopa-treated patient with Parkinson's disease

Ling H, Petrovic I, Day BL, Lees AJ.

J Neurol. 2012 Nov;259(11):2419-23. doi: 10.1007/s00415-012-6515-5. Epub 2012 May 10.

Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation

Basso M, Berlin J, Xia L, Sleiman SF, Ko B, Haskew-Layton R, Kim E, Antonyak MA, Cerione RA, Iismaa SE, Willis D, Cho S, Ratan RR.

J Neurosci. 2012 May 9;32(19):6561-9. doi: 10.1523/JNEUROSCI.3353-11.2012.

Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models

Xiong N, Long X, Xiong J, Jia M, Chen C, Huang J, Ghoorah D, Kong X, Lin Z, Wang T.

Crit Rev Toxicol. 2012 Aug;42(7):613-32. doi: 10.3109/10408444.2012.680431. Epub 2012 May 11.

Long-term benefit from deep brain stimulation of the subthalamic nucleus: is it for everyone?

Vitek JL.

Alzheimers Res Ther. 2012 May 9;4(3):13. doi: 10.1186/alzrt111.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias